FDA (Tag Archives)
Subscribe to PricePlow's Newsletter and FDA Alerts
Inside Look at Veritacor Manufacturing: From Formula to Fulfillment
After spending multiple days at Veritacor Manufacturing in Luling, Texas for Episode #178 of the PricePlow Podcast, we captured exclusive footage showing exactly how modern supplement manufacturing works. While the full facility tour revealed the impressive scale of their 32,500 square foot NSF-certified operation, today we're diving deeper into the specific processes that transform ideas […]
Continue Reading →
NNB Nutrition's Longevity Platform: Extending Your Youth Span with Science-Backed Ingredients
The conversation around aging has shifted. We're no longer just talking about adding years to life, we're focused on adding life to those years. Industry pioneer Shawn Wells captures this evolution perfectly: the concept of "youth span" has replaced health span as our primary motivator. When we look at our peers, we don't just […]
Continue Reading →
Inside Veritacor Supplement Manufacturing: GMP Excellence, NSF Certification, and the Future of Production | Episode #178
On Episode #178 of the PricePlow Podcast, Ben and guest co-host Joey Savage take listeners inside Veritacor Manufacturing in Luling, Texas, for an exclusive facility tour and in-depth conversation with founders Frank Santos and Derek Curtiss. This episode provides a rare behind-the-scenes look at what it takes to build and operate an NSF-certified, […]
Continue Reading →
The Creapure Connection: Why Nutristat Only Uses Premium Creatine Monohydrate
In the ever-evolving world of sports supplements, creatine stands as one of the most extensively researched and proven performance enhancers. But here's something many consumers don't realize: not all creatine is created equal.
Nutristat and Their Commitment to Creapure®Nutristat, a brand that's quietly built a reputation for uncompromising quality, makes a deliberate […]
Continue Reading →
Navigating Uncertainty: Tariffs, FDA Oversight, and Supplement Trends at SupplySide Connect New Jersey 2025 | Episode #164
For Episode #164 of the PricePlow Podcast, Ben Kane sits down with Cassie Smith (Senior Editorial Content Director at SupplySide) and Josh Long (Associate Editorial Director at SupplySide Supplement Journal) for a dynamic discussion recorded live at SupplySide Connect New Jersey 2025. This wide-ranging conversation dives into the most pressing issues facing the […]
Continue Reading →
FDA SUED by the Supplement Industry Over NMN Legality
After a long wait and total inaction from the FDA, their hand has now been forced -- the dietary supplement industry has made its move against the agency: The Natural Products Association (NPA) has sued the FDA over the status of NMN.[1]
What is NMN, and is it Worth the Fight?NMN is a […]
Continue Reading →
NMN, FDA, and the Supplement Industry's Fight Against Pharma (Updated 8/28/24)
Continue Reading →
Supplements Take on DC: Natural Products Association Fly-In Day 2024 | Episode #139
The crew is back in Washington DC for the 2024 NPA Fly-In Day, held on May 22, 2024! This podcast was filmed the night before, featuring a star-studded cast that includes:
Jim Emme, CEO of NOW Foods Kyle Turk, Natural Products Association Rick Collins, the one and only Mike DiMaggio, Chief[…]Continue Reading →
Who is STRIPED? Meet The Harvard Organization Taking On Supplements
The dietary supplement industry is under a massive, well-organized attack, and this time, it's not just coming from heavy-handed Senate bills. It comes from a Harvard organization named STRIPED, who's using a unique attack vector: adolescent eating disorders.
The industry needs to take note, because this group is well-funded and they are seizing power […]
Continue Reading →
Dick Durbin is Up to No Good in the Dietary Supplement Industry Again
On March 18, 2024, United States Senator Dick Durbin of Illinois sent a letter to four dietary supplement industry trade associations demanding action against the inclusion of dangerous and illegal ingredients in products marketed as supplements.[1-5]
The letter focuses specifically on tianeptine, a compound sold as an antidepressant in several European countries that has […]
Continue Reading →